Rate My Professor Manuel Espinoza

Manuel Espinoza is Associate Professor in the Division of Health Economics, Policy and Management in the School of Public Health at The University of Hong Kong. He earned his MD and MSc in Epidemiology from Pontificia Universidad Católica de Chile, MSc in Biostatistics from Universidad de Chile, MSc in Health Economics from the University of York, UK, and PhD in Economics from the University of York. Previously, he served as Associate Professor at the School of Public Health, Pontificia Universidad Católica de Chile. His professional career includes consulting roles with the World Bank, Inter-American Development Bank, United Nations Office of Project Services, and the Center for Global Development. These engagements involved developing health benefit plans in Argentina, Honduras, the Dominican Republic, and Chile, as well as policy impact analysis in Belize and Chile, and strategic purchasing for high-cost technologies in Mexico and Chile.

Espinoza specializes in health technology assessment and health economics, focusing on economic evaluation, priority setting in health, new methods for heterogeneity and equity in economic evaluation, and value frameworks for health decision-making. He has held major leadership positions such as Director of the Board of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), President of the ISPOR Latin America Consortium, co-editor of Value in Health, Editor-in-Chief of Value in Health Regional Issues, and Chair of the Latin America Policy Forum of Health Technology Assessment International (HTAi). Key publications include "Improving efficiency in healthcare: lessons from successful health policies in Chile" (Archives of Medical Research, 2025), "Good Practices for Health Technology Assessment Guideline Development" (Value in Health, 2025), "The Socioeconomic Distribution of Life Expectancy and Healthy Life Expectancy in Chile" (International Journal for Equity in Health, 2023), "Economic evaluation of a Multimorbidity patients centered care model implemented in the Chilean Public Health System" (BMC Health Services Research, 2023), "Health and economic effects on patients with Type 2 Diabetes Mellitus in the long run" (Diabetology & Metabolic Syndrome, 2022), "Social value and individual choice" (Health Economics, 2018), and "The value of heterogeneity for cost-effectiveness subgroup analysis" (Medical Decision Making, 2014). His contributions have influenced health policy and decision-making in multiple countries.